Weaning of inhaled nitric oxide: is there a best strategy?
Background: Inhaled nitric oxide (iNO) has been used in the treatment of pulmonary hypertension in neonates for many years. iNO was approved by the FDA in 1999 for hypoxic respiratory failure (HRF) in term and near term infants, defined as > 34 weeks gestational age (GA). iNO is used for persiste...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hygeia Press di Corridori Marinella
2015-04-01
|
| Series: | Journal of Pediatric and Neonatal Individualized Medicine |
| Subjects: | |
| Online Access: | https://www.jpnim.com/index.php/jpnim/article/view/274 |